Guided Tour
 View Your Account
 Shop for Stocks
 Research Stocks
 Educate Yourself
 Family Investing
 Retirement Focus
 Resource Center
 Our Strategy
 About Us
 Helpdesk
 Home
Google Custom Search
Company Profile
 
Symbol Lookup
Profile
PFE - Pfizer Inc (NYSE) 4:00 PM ET, 11/20/2009 
 Last: 18.36 Change: +0.25 %Change: +1.38% Volume: 60,976,316  
Detailed QuoteSEC FilingsProfileNewsChart
Pfizer, Incorporated (NYSE:PFE)
235 East 42nd Street
New York, NY 10017-5755
Phone: (212) 573-2323
Fax: (212) 573-7851
http://www.pfizer.com
Pfizer Inc. is a research-based global pharmaceutical company applying innovative science to improve world health. It discovers, develops, manufactures and markets prescription medicines for humans and animals. The company operates in two business segments: Pharmaceutical and Animal Health. The Pharmaceutical segment includes products that prevent and treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye disease and endocrine disorders, among others. With medicines across 11 therapeutic areas, the company helps to treat and prevent many of the most common and most challenging conditions of its time. The Animal Health segment discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Among the products it market are parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. The company's operations include several pharmaceutical sales organizations. Its structure aligns the sales, marketing, and medical functions to work closely in tandem along the same therapeutic groups of products, reinforcing common coordination, focus, and accountability across the organizations. The company's prescription pharmaceutical products are sold mainly to wholesalers, but it also sells directly to retailers, hospitals, clinics, government agencies and pharmacies. It also works with MCOs, PBMs, employers and other appropriate healthcare providers to assist them with disease management, patient education and other tools that help their medical treatment routines. The company's Animal Health business also uses its own sales organization to promote its products. Its advertising and promotion are generally targeted to health professionals, directly and through veterinary journals. Animal health products are sold through veterinarians, distributors and retail outlets as well as directly to users. These products are also marketed through print and television advertising. The products are sold around the world under brand-name, logo and certain product design trademarks. Raw materials essential to the company's businesses are purchased worldwide in the ordinary course of business from numerous suppliers. In general, these materials are available from multiple sources.
 Sector:Pharmaceuticals 
 Number of Employees:81,800 
 Share Information
 Shares
 Outstanding:
8.07B 
 Market Cap:148.16B 
 Cash Flow (per sh):1.52 
 Book Value:8.19 
 Fundamentals
 EPS:1.19 
 P/E Ratio:15.43 
 Dividend:0.16 
 Yield:3.49 
 Management Effectiveness
 Return on Equity (1 year):12.30 
 Return on Assets (1 year):5.80 
 Return on Investment (1 year):7.70 
 Performance
 52wk High
 (1/5/2009):
18.48 
 52wk Low
 (3/2/2009):
11.62 
 Key Financials
Revenue Total Net Income Earnings/Share EBITDA Long Term Debt 
 2008$48.30B $8.10B $1.20 $20.12B $7.96B 
 2007$48.42B $8.14B $1.17 $15.54B $7.31B 
MarketWatch

© MarketWatch, Inc. 2009. All rights reserved. Subject to the Terms of Use. Designed and powered by Dow Jones Client Solutions.
MarketWatch, the MarketWatch logo, BigCharts and the BigCharts logo are registered trademarks of MarketWatch, Inc.
Dow Jones is the registered trademark of Dow Jones & Company, Inc.

Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc.


BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy. Any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs. The security and information listed above and is being provided for informational purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy and past performance is no guarantee of future results.

The BUYandHOLD website contains links to third-party websites on the Internet. BUYandHOLD provides these links to these websites only as a convenience to users of the website. Links on the BUYandHOLD website are not endorsements by BUYandHOLD or Freedom Investments, implied or express, of the linked sites or any products, services or links in such sites; and no information in such sites has been endorsed or approved by BUYandHOLD. Linked sites are not under the control of BUYandHOLD or Freedom Investments, and we are not responsible for the contents of any linked site or any link contained in a linked site. No information contained in the BUYandHOLD website or accessed through any linked site, or any link contained in a linked site, constitutes a recommendation by BUYandHOLD or Freedom Investments to buy, sell or hold any security, financial product or instrument. Information accessed through linked sites is not, nor should be construed as, an offer or a solicitation of an offer, to buy or sell securities by BUYandHOLD or Freedom Investments. BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy, and any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Copyright © 1999 – 2009 Freedom Investments. All Rights Reserved.
Freedom Investments, Inc. Member FINRA/SIPC
Privacy & Security